139 related articles for article (PubMed ID: 10703687)
1. ACE inhibitor dosage at the time of listing predicts survival.
Berger R; Kuchling G; Frey B; Kozanly I; Pacher R; Stanek B
J Heart Lung Transplant; 2000 Feb; 19(2):127-33. PubMed ID: 10703687
[TBL] [Abstract][Full Text] [Related]
2. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Chen YT; Wang Y; Radford MJ; Krumholz HM
Am Heart J; 2001 Mar; 141(3):410-7. PubMed ID: 11231438
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
5. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
McDermott MM; Lee P; Mehta S; Gheorghiade M
Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
[TBL] [Abstract][Full Text] [Related]
6. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
Kvan E; Reikvam A;
Eur J Clin Pharmacol; 2004 May; 60(3):205-10. PubMed ID: 15034703
[TBL] [Abstract][Full Text] [Related]
7. Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx.
Berger R; Strecker K; Hülsmann M; Frey B; Pacher R; Stanek B
J Heart Lung Transplant; 2000 Nov; 19(11):1081-8. PubMed ID: 11077226
[TBL] [Abstract][Full Text] [Related]
8. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
9. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Giles TD; Fisher MB; Rush JE
Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
[TBL] [Abstract][Full Text] [Related]
10. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
[TBL] [Abstract][Full Text] [Related]
11. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
Massie BM; Armstrong PW; Cleland JG; Horowitz JD; Packer M; Poole-Wilson PA; Rydén L
Arch Intern Med; 2001 Jan; 161(2):165-71. PubMed ID: 11176729
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
Packer M; Poole-Wilson PA; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Rydén L; Thygesen K; Uretsky BF
Circulation; 1999 Dec; 100(23):2312-8. PubMed ID: 10587334
[TBL] [Abstract][Full Text] [Related]
13. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
[TBL] [Abstract][Full Text] [Related]
14. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Mazzotta G; Vecchio C
G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
[TBL] [Abstract][Full Text] [Related]
15. [ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples].
Fischer M; Bässler A; Hengstenberg C; Holmer S; Mayer B; Löwel H; Riegger G; Klein G; Schunkert H
Z Kardiol; 2001 Feb; 90(2):104-10. PubMed ID: 11262999
[TBL] [Abstract][Full Text] [Related]
16. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
[TBL] [Abstract][Full Text] [Related]
17. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
[TBL] [Abstract][Full Text] [Related]
18. Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.
Tu K; Mamdani M; Kopp A; Lee D
Am J Cardiol; 2005 Jan; 95(2):283-6. PubMed ID: 15642572
[TBL] [Abstract][Full Text] [Related]
19. Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
Remme WJ
Cardiovasc Drugs Ther; 2001 Nov; 15(6):475-7. PubMed ID: 11916355
[No Abstract] [Full Text] [Related]
20. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.
Pilote L; Abrahamowicz M; Eisenberg M; Humphries K; Behlouli H; Tu JV
CMAJ; 2008 May; 178(10):1303-11. PubMed ID: 18458262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
